Professional Medical Expertise Co. (9574.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Professional Medical Expertise Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 419↑33.7% | 313↑25.2% | 250↑42.1% | 176↑34.1% | 131 | |
| Cost of Revenue | 242↑39.0% | 174↑26.2% | 138↑44.7% | 95↑43.1% | 67 | |
| Gross Profit | 176↑31.7% | 134↑19.6% | 112↑39.0% | 81↑24.8% | 65 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 36↑452.8% | 7↑21.6% | 5↓68.8% | 17 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 58↑366.9% | 12↑61.8% | 8↓68.1% | 24 | |
| SG&A Expenses | 116↑23.1% | 94↑396.9% | 19↑45.2% | 13↓67.4% | 40 | |
| Other Expenses | 0.84↓75.6% | 3↓94.2% | 60↑33.8% | 45 | 0.00 | |
| Operating Expenses | 117↑19.6% | 98↑24.2% | 79↑36.4% | 58↑43.8% | 40 | |
| Total Costs & Expenses | 359↑32.0% | 272↑25.5% | 217↑44.5% | 150↑40.5% | 107 | |
| Operating Results | ||||||
| Operating Income | 60↑50.1% | 40↑19.1% | 33↑28.2% | 26↑6.4% | 24 | |
| Depreciation & Amortization | 9↑76.0% | 5↓10.3% | 5↑77.6% | 3↑29.4% | 2 | |
| EBITDA | 68↑49.2% | 46↑16.3% | 39↑37.6% | 29↑6.8% | 27 | |
| EBIT | 60↑46.0% | 41↑20.5% | 34↑32.2% | 26↑5.1% | 24 | |
| Interest & Other Income | ||||||
| Net Interest Income | -10↑4.8% | -11↓56.2% | -7↓46.1% | -5↓84.9% | -3 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 10↓4.8% | 11↑56.2% | 7↑46.1% | 5↑84.9% | 3 | |
| Non-Operating Income | 0.00↑100.0% | -1↓112.6% | -0.52↓229.9% | 0.40↑402.6% | 0.08 | |
| Other Income / Expenses | -14↓43.4% | -10↓58.5% | -6↓19.2% | -5↓94.5% | -3 | |
| Income Before Tax | 46↑52.2% | 30↑10.2% | 27↑30.4% | 21↓4.3% | 22 | |
| Income Tax Expense | 4↑68.3% | 2↓0.4% | 2↑28.1% | 2↑55.5% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 42↑50.8% | 28↑11.3% | 25↑30.7% | 19↓7.8% | 21 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 42↑50.8% | 28↑11.3% | 25↑30.7% | 19↓7.8% | 21 | |
| Bottom-Line Net Income | 42↑50.8% | 28↑11.3% | 25↑30.7% | 19↓7.8% | 21 | |
| EPS (Basic) | 11.92↑50.9% | 7.90↑11.3% | 7.10↑30.8% | 5.43↓7.8% | 5.89 | |
| EPS (Diluted) | 11.92↑50.9% | 7.90↑11.3% | 7.10↑30.8% | 5.43↓7.8% | 5.89 | |
| Weighted Average Shares | 4↑0.0% | 4↑0.0% | 4↑0.0% | 4↑0.0% | 4 | |
| Weighted Average Diluted Shares | 4↑0.0% | 4↑0.0% | 4↑0.0% | 4↑0.0% | 4 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.